ARS Pharmaceuticals, Inc.SPRYNASDAQ

Revenue (LTM)

$84M

-5.5% YoY

Net Income (LTM)

$-171M

-2241.8% YoY

Free Cash Flow

$-171M

Revenue CAGR (5Y)

+36.4%

Marginsdeclining

FCFTurned negative

Now unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	6	1↓76.1%	0↓97.7%	89↑297063.3%	84↓5.5%
Gross Profit	5	1↓75.1%	0↓97.7%	69↑228540.0%	64↓6.9%
Operating Income	-19	-36↓82.6%	-68↓90.1%	-3↑95.4%	-179↓5720.6%
Net Income	-20	-35↓71.3%	-54↓56.8%	8↑114.7%	-171↓2241.8%
EBITDA	-19	-35↓82.9%	-67↓91.6%	-3↑95.5%	-178↓5828.1%
EPS Diluted	-0.70	-0.87↓24.3%	-0.57↑34.5%	0.08↑113.7%	-1.74↓2327.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	60	211↑250.5%	71↓66.3%	51↓28.4%	41↓18.7%
Total Current Assets	61	278↑357.3%	232↓16.6%	334↑44.4%	285↓14.8%
Total Assets	61	281↑358.0%	233↓17.1%	351↑50.6%	328↓6.7%
Total Current Liabilities	8	5↓33.5%	2↓56.1%	23↑880.3%	39↑67.0%
Total Liabilities	93	9↓90.8%	2↓71.6%	94↑3786.1%	213↑126.2%
Total Equity	-31	273↑972.7%	231↓15.4%	257↑11.3%	114↓55.5%
Total Debt	9	0↓94.7%	0↓43.0%	0↓84.7%	97↑230761.9%
Net Debt	-51	-210↓311.6%	-71↑66.3%	-51↑28.2%	56↑209.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-18	-40↓128.2%	-59↓47.9%	14↑122.9%	-171↓1361.2%
Capital Expenditure	-0	-0↓261.8%	-0↑12.1%	-1↓221.7%	-0↑39.8%
Free Cash Flow	-18	-40↓128.6%	-59↓47.6%	13↑121.8%	-171↓1418.5%
Stock-Based Comp	3	6↑106.5%	9↑58.1%	15↑57.4%	22↑52.0%
Net Change in Cash	36	150↑323.3%	-140↓192.7%	-20↑85.6%	-10↑52.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance